Lexaria Bioscience ($LXRP) announced that it has entered into a joint venture with Neutrisci International for producing and commercializing edible cannabinoid mouth-melt products using its lipid delivery technology. The products will also use Neutrisci’s pterostilbene tablet form factor. The companies plans to secure licenses in California, Colorado and Canada to manufacture and sell mouth-melt products containing THC.
Abbott Laboratories ($ABT) announced that it has agreed to acquire Alere ($ALR) with modified terms and conditions. The new pricing for the company is at $51 per share, down from $56 per share ,announced in February, 2016. The new deal is expected to be worth $5.3 billion. The companies also agreed to dismiss their respective lawsuits.